Problems of viral gastroenteritis in adults
https://doi.org/10.22625/2072-6732-2025-17-2-42-54
Abstract
The review is devoted to a challenging problem of modern infectology – viral gastroenteritis. The improvement of laboratory diagnostic methods has made it possible to identify a significant number of viral pathogens for which gastroenteritis has been established or is considered possible. The main pathogens are rotaviruses, noroviruses, sapoviruses, astroviruses, etc., while norovirus is the primary cause of sporadic cases and outbreaks of gastroenteritis.
Adults experience a predominantly mild and short-term self-limiting course of the disease. The main risk factor for severe course and unfavorable outcome of viral gastroenteritis in adults is any immunodeficiency condition, and therefore the patient’s age, concomitant diseases, and the use of immunosuppressive therapy should be taken into account.
Cancer patients and recipients of solid organ and blood stem cell transplantation are a particularly vulnerable group. In these patients, viral gastroenteritis often becomes chronic with a long period of viral shedding, which is frequently accompanied by the virus mutation. In turn, a viral infection can affect the course of non-infectious diseases and therapeutic approach, resulting in the need to discontinue immunosuppressive agents and causing post-transplant complications.
About the Authors
T. V. Antonova
First Saint-Petersburg State Medical University named after I.P. Pavlov
Russian Federation
Russian Federation
Saint-Petersburg
O. E. Pobegalova
First Saint-Petersburg State Medical University named after I.P. Pavlov
Russian Federation
Russian Federation
Saint-Petersburg
O. V. Gorchakova
First Saint-Petersburg State Medical University named after I.P. Pavlov
Russian Federation
Russian Federation
Saint-Petersburg
D. A. Lioznov
First Saint-Petersburg State Medical University named after I.P. Pavlov;
Research Institute of Influenza named after A.A. Smorodintsev
Russian Federation
Russian Federation
Saint-Petersburg
References
1. Kumate, J. Infectious diseases in the 21st century / J. Kumate // Arch. Med. Res. – 1997. – Vol. 28, №2. – P. 155-161.
2. Cohen, M.L. Changing patterns of infectious disease / M.L. Cohen // Nature. – 2000. – Vol. 406, № 6797. – P. 762-767.
3. Wilhelmi, I. Viruses causing gastroenteritis / I. Wilhelmi, E. Roman, A. Sánchez-Fauquier // Clin. Microbiol. Infect. – 2003. – Vol. 9, №4. – P. 247-262.
4. Farthing, M. Acute diarrhea in adults and children: a global perspective / M. Farthing, M.A. Salam, G. Lindberg, et al. // J. Clin. Gastroenterol. – 2013. – Vol. 47, №1. – P. 12-20.
5. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossijskoj Federacii v 2023 godu: Gosudarstvennyj doklad. M.: Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya cheloveka. – 2024. – 364 s.
6. Lopman, B.A. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control / B.A. Lopman, D. Steele, C.D. Kirkwood, U.D. Parashar // PLoS Med. – 2016. – Vol. 13, №4. – e1001999.
7. Meier, J.L. Viral Acute Gastroenteritis in Special Populations / J.L. Meier // Gastroenterol. Clin. North. Am. – 2021. – Vol.50, №2. – P. 305-322.
8. Sapega, E.YU. Sovremennye osobennosti epidemiologicheskih proyavlenij ostryh kishechnyh infekcij virusnoj etiologii u detej i podrostkov v Sahalinskoj oblasti / E.YU. Sapega, L.V. Butakova, O.E. Trocenko // Zhurnal infektologii. – 2024. – T.16, № 3. – S.123-132.
9. Kajon, A.E. Characterization of Human Adenoviruses of Medical Importance: Isolation of Infectious Virus from Clinical Specimens and Molecular Typing / A.E. Kajon, D.M. Lamson, K.S. George // Curr. Protoc. – 2023. – Vol. 3, №11. – e916.
10. Kang, H.M. The role of rapid syndrome diagnostic testing of gastrointestinal pathogens as a tool to support clinical decision-making in the pediatric emergency department / H.M Kang., I.H. Yu, D.K. Jeong // Ann Klin. Microbiol. Antimicrobial. – 2024. – Vol. 23, №1. – P. 3.
11. Ambrosius-Eichner, J. Comparative evaluation of the detection rate, workflow and associated costs of a multiplex PCR panel versus conventional methods in diagnosis of infectious gastroenteritis / J. Ambrosius-Eichner, M. Hogardt, A. Berger, et al. // J. Med. Microbiol. – 2024. – Vol. 73, №2.
12. Mohammad, H.A. Analysis of viral diversity in stool samples from infants and children with acute gastroenteritis in Kuwait using Metagenomics approach / H.A. Mohammad, N.M. Madi, W. Al-Nakib // Virol. J. – 2020. – Vol. 17, №1. – P. 10.
13. Babaei, A. Recent Advances in Earl Diagnosis of Viruses Associated with Gastroenteritis by Biosensors / A. Babaei, N. Rafiee, B. Taheri, et al. // Biosensors (Basel). – 2022. – Vol. 12, №7. – P. 499.
14. Foulongne, V. Le bocavirus humain (HBoV) [Human bocavirus (HBoV)] / V. Foulongne, M. Segondy. // Pathol. Biol. (Paris). – 2009. – Vol. 57, №2. – P. 197-202.
15. Grohmann, G.S. Enteric viruses and diarrhea in HIVinfected patients. Enteric Opportunistic Infections Working Group / G.S. Grohmann, R.I. Glass, H.G. Pereira, et al. // N. Engl. J. Med. – 1993. – Vol. 329, №1. – P. 14-20.
16. Ghosh, S. The True Host/s of Picobirnaviruses / S. Ghosh, Y.S. Malik. // Front Vet. Sci. – 2021- Vol. 7. – P. 615293.
17. Glass, R.I. Gastroenteritis viruses: an overview / R.I. Glass, J. Bresee, B. Jiang, et al. // Novartis Found Symp. – 2001. – Vol. 238. – P. 5-19; discussion 19-25.
18. Krenzer, M.E. Viral gastroenteritis in the adult population: the GI peril / M.E. Krenzer // Crit Care Nurs. Clin. North. Am. – 2012. – Vol. 24, №4. – P. 541-553.
19. Maleev, V.V. Novye napravleniya terapii ostryh infekcionnyh diarej / V.V. Maleev, A.A. Ploskireva // RMZH. – 2019. -№ 5. – S.45–48.
20. Eckardt, A.J. Viral gastroenteritis in adults / A.J. Eckardt, D.C. Baumgart. // Recent. Pat. Antiinfect. Drug. Discov. – 2011. – Vol. 6, №1. – P. 54-63.
21. Anderson, E.J. Rotavirus infection in adults / E.J. Anderson, S.G. Weber // Lancet Infect. Dis. – 2004. – Vol.4, №2. – P. 91-99.
22. Anderson, E.J. Rotavirus in adults requiring hospitalization / E.J. Anderson, B.Z. Katz, J.A. Polin, et al. // J. Infect. – 2012. – Vol. 64, №1. – P. 89-95.
23. Pazdiora, P. Rotavirus gastroenteritis in the Czech Republic before the start of vaccination / P. Pazdiora,C. Beneü // Epidemiol. Mikrobiol. Imunol. – 2013. –Vol. 62, № 4. – P. 131–137.
24. Anderson, E.J. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination / E.J. Anderson, D.B. Shippee, M.H. Weinrobe, et al. // Clin. Infect. Dis. – 2013. – Vol. 56, №6. – P.755-760.
25. Luchs, A. Rotavirus in adults, Brazil, 2004-2011: G2P[4] dominance and potential impact on vaccination / A. Luchs, A. Cilli, S.G. Morillo, et al. // Braz. J. Infect. Dis. – 2014. – Vol. 18, №1. – P. 53-59.
26. Yandle, Z. Indirect impact of rotavirus vaccination on viral causes of acute gastroenteritis in the elderly / Z. Yandle, S. Coughlan, J. Dean, et al. // J. Clin. Virol. – 2021. – Vol. 137. – P. 104780.
27. Sharma, P.C. Navigating Viral Gastroenteritis: Epidemiological Trends, Pathogen Analysis, and Histopathological Findings / P.C. Sharma, M. McCandless, S.P. Sontakke, et al. // Cureus. – 2024. – Vol. 16, №5. – e61197.
28. Burke, R.M. Norovirus and Other Viral Causes of Medically Attended Acute Gastroenteritis Across the Age Spectrum: Results from the Medically Attended Acute Gastroenteritis Study in the United States / R.M. Burke, C.P. Mattison, Z. Marsh, et al. // Clin. Infect. Dis. – 2021. – Vol. 73, №4. – e913-e920.
29. Jansen, A. Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study / A. Jansen, K. Stark, J. Kunkel, et al. // BMC Infect. Dis. – 2008. – Vol. 8. – P. 143.
30. Bresee, J.S. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States / J.S. Bresee, R. Marcus, R.A.Venezia, et al. // J. Infec.t Dis. – 2012. – Vol. 205, №9. – P. 1374-1381.
31. Lyubeznova, O.N. Rotavirusnaya i norovirusnaya infekcii u vzroslyh / O.N. Lyubeznov, E.O. Utenkova // Medicinskij vestnik Severnogo kavkaza. – 2017. – T.12, № 1. – S.32 – 35.
32. Krasnova, E.I. Ostryj norovirusnyj gastroenterit u vzroslyh. / E.I. Krasnova, D.V. Kapustin, N.I. Hohlova i dr. // Eksperimental’naya i klinicheskaya gastroenterologiya. – 2017. – № 9. – S. 25-29.
33. Luchs, A. Outbreak of G2P[4] rotavirus gastroenteritis in a retirement community, Brazil, 2015: An important public health risk? / Luchs A, Madalosso G, Cilli A, et al. // Geriatr. Nurs. – 2017. – Vol. 38, №4. – P. 283-290.
34. Cardemil, C.V. Rotavirus Investigation Team. Two rotavirus outbreaks caused by genotype G2P[4] at large retirement communities: cohort studies / C.V. Cardemil, M.M. Cortese, A. Medina-Marino, et al. // Ann Intern. Med. – 2012. – Vol. 157, №9. – P. 621-631.
35. Edmonson, L.M. Report of a rotavirus outbreak in an adult nursing home population / L.M. Edmonson, J.O. Ebbert, J.M. Evans. // J Am Med. Dir. Assoc. – 2000. – Vol. 1, №4. – P. 175-179.
36. Lopman, B.A. Viral gastroenteritis outbreaks in Europe, 1995-2000 / B.A. Lopman, M.H. Reacher, Y. Van Duijnhoven, et al. // Emerg. Infect. Dis. – 2003. – Vol. 9, №1. P- 90-96.
37. Lopman B. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant / B. Lopman, H. Vennema, E. Kohli, et al. // Lancet. – 2004. – Vol. 363, № 9410. – P. 682-688.
38. Sagalova, O.I. Norovirusnaya infekciya v mnogoprofil’nyh stacionarah dlya vzroslyh / O.I. Sagalova, I.V. Bryzgalova, A.T. Podkolzin, V.V.Maleev // Terapevt. arh. – 2009. – T.81, №4. – S.60 -64.
39. Tsai, H. Norovirus disease among older adults / H. Tsai, P. Yune, M. Rao // Ther Adv. Infect. Dis. – 2022. – Vol. 14, №9. – P: 20499361221136760.
40. Jarchow-Macdonald, A.A. First report of an astrovirus type 5 gastroenteritis outbreak in a residential elderly care home identified by sequencing. / A.A. Jarchow-Macdonald, S. Halley, D. Chandler, et al. // J. Clin. Virol. – 2015. – Vol.73. – P. 115-119.
41. Du, Y. Global burden and trends of rotavirus infectionassociated deaths from 1990 to 2019: an observational trend study / Y. Du, C. Chen, X. Zhang, et al. // Virol. J. – 2022. – Vol. 19, №1. – P.166.
42. Zhang, X. Global Burden and Trends of Norovirus-Associated Diseases From 1990 to 2019: An Observational Trend Study / X. Zhang, C. Chen, Y. Du, et al. // Front Public Health. – 2022. – Vol. 10. – P. 905172.
43. Bruijning-Verhagen, P. Rotavirus disease course among immunocompromised patients; 5-year observations from a tertiary care medical centre / P. Bruijning-Verhagen, M.D. Nipshagen, H. de Graaf, M.J.M. Bonten // J. Infect. – 2017. – Vol.75, №5. – P. 448-454.
44. Hohlova, N.I. Norovirusnaya infekciya (obzor literatury) / N.I. Hohlova, D.V. Kapustin, E.I. Krasnova, I.YA. Izvekova // ZHurnal infektologii. – T.10, № 1. – 2018. – S.5-14.
45. Roos-Weil, D. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea / D. Roos-Weil, K. Ambert-Balay, F. Lanternier, et al. // Transplantation. – 2011. – Vol. 92, №1. – P. 61-69.
46. Gras, J. Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study / J. Gras, M. Abdel-Nabey, A. Dupont et al. // BMC Infect. Dis. – 2021. – Vol. 21. – P.351.
47. Amin, K. Diarrhea in a Patient With Combined KidneyPancreas Transplant / K. Amin, V. Choksi, S.S. Farouk, M.A. Sparks // Am J. Kidney Dis. – 2021. – Vol. 7, №2. – P. A13-A16.
48. Echenique, I.A. Prolonged norovirus infection after pancreas transplantation: a case report and review of chronic norovirus / I.A. Echenique, V. Stosor, L. Gallon, et al. // Transpl. Infect. Dis. – 2016. – Vol. 18, №1. – P. 98-104.
49. Callegari, M. Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study /M. Callegari, L.A. Danziger-Isakov, A. Rose, et al. // Transpl. Infect. Dis. – 2024. – Vol.26, №3. – e14270.
50. Lemes, L.G. Prospective study on Norovirus infection among allogeneic stem cell transplant recipients: prolonged viral excretion and viral RNA in the blood / L.G. Lemes, T.S. Corrêa, F.S. Fiaccadori, et al. // J. Clin. Virol. – 2014. – Vol. 61, №3. – P. 329-333.
51. Cintron, M. Prevalence of astrovirus and sapovirus among adult oncology patients with acute gastroenteritis using a multiplexed gastrointestinal pathogen PCR panel / M. Cintron, K. Jani, J. Madhavappallil, et al. // Eur. J. Clin. Microbiol. Infect. Dis. – 2024. – Vol. 43, №3. – P. 525-531.
52. Woodward, J. Chronic norovirus infection and common variable immunodeficiency / J. Woodward, E. Gkrania-Klotsas, D. Kumararatne // Clin. Exp. Immunol. – 2017. –Vol. 188, №3. – P. 363-370.
53. González-Morcillo, G. Ribavirin-resistant chronic norovirus infection-associated enteropathy in common variable immunodeficiency. Case report and review of the literature / G. González-Morcillo, B. Calderón-Hernanz, X. Serrano-López de Las, et al. // Clin. Res. Hepatol. Gastroenterol. – 2022. – Vol. 46, №8. – P.101956.
54. Moral Moral, P. Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency / P. Moral Moral, D. Cabañero-Navalon, V. Garcia-Bustos, et al. // Rev. Esp. Quimioter. – 2022. – Vol. 3, № 3. – P.63-66.
55. Van Kampen, J.J.A. Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency / J.J.A.van Kampen, V.A.S.H. Dalm, P.L.A. Fraaij, et al. // J. Infect. Dis. – 2022. – Vol. 226, №10. – P.1781-1789.
56. Ottosson, L. Long Term Norovirus Infection in a Patient with Severe Common Variable Immunodeficiency / L. Ottosson, M. Hagbom, R. Svernlöv, et al. // Viruses. – 2022. – Vol. 14, №8. – P. 1708.
57. Kondapi, D.S. Norovirus in Cancer Patients: A Review / D.S. Kondapi, S. Ramani, M.K. Estes, et al. // Open Forum Infect. Dis. – 2021. – Vol. 8, №6. – ofab126.
58. Hayashi, T. Human norovirus cultivation systems and their use in antiviral research / T. Hayashi, S. Kobayashi, J. Hirano, K. Murakami // J. Virol. – 2024. – Vol. 98, №4. – e0166323.
59. Chen, J. Advances in human norovirus research: Vaccines, genotype distribution and antiviral strategies / J. Chen, Z. Cheng, J. Chen, et al. // Virus. Res. – 2024. – Vol. 350. – P.199486.
60. Liu, Y. CX-6258 hydrochloride hydrate: A potential nonnucleoside inhibitor targeting the RNA-dependent RNA polymerase of norovirus / Y. Liu, Q. Li, H. Shao, et al. // Virology. – 2024. – Vol. 595. – P.110088.
61. Santos-Ferreira, N. Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids / N. Santos-Ferreira, J. Van Dycke, W. Chiu, et al. // Antiviral. Res. – 2024. – Vol. 223. – P.105839.
62. Lapin, V.A. Poluchenie rekombinantnogo belka VP1 norovirusa i ego antigennye i immunogennye svojstva / V.A.Lapin, D.V. Novikov, E.V. Mohonova E.V. i dr. // Zhurnal mikrobiologii, epidemiologii i immunobiologii. – 2024. – T. 101, №5. – S. 661-667.
Review
For citations:
Antonova T.V., Pobegalova O.E., Gorchakova O.V., Lioznov D.A. Problems of viral gastroenteritis in adults. Journal Infectology. 2025;17(2):42-54. (In Russ.) https://doi.org/10.22625/2072-6732-2025-17-2-42-54
Views:
58
.png)
.png)
Email this article 